-
公开(公告)号：US20180110838A1
公开(公告)日：2018-04-26
申请号：US15564783
申请日：2016-04-06
申请人： Laboratoire Francais du Fractionnement des Biotechnologies , CTRE Hospitalier Universitaire de Lille , Universite Lille 2 Droit et Sante
摘要： The present invention relates to a von Willebrand factor composition for the prevention and/or the treatment of haemorrhage and/or bleeding in patients with mechanical circulatory support.
-
2.发明申请公开(公告)号：US20170101478A1
公开(公告)日：2017-04-13
申请号：US15333519
申请日：2016-10-25
申请人： LABORATOIRE FRANCAIS DU FRACTIONNEMENT DES BIOTECHNOLOGIES , CENTRE REGIONAL DE LUTTE CONTRE LE CANCER , I.N.S.E.R.M. (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , UNIVERSITE MONTPELLIER 1
IPC分类号： C07K16/28 , C07K16/30 , A61K39/395 , A61K9/00 , A61K31/282 , A61K31/337
CPC分类号： C07K16/2869 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K33/24 , A61K39/39533 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/28 , C07K16/3069 , C07K2317/24 , C07K2317/92 , A61K2300/00
摘要： The invention relates to novel pharmaceutical compositions including, as active ingredient, an antibody binding the human anti-Müllerian hormone type II receptor (AMHR-II) and an anticancer agent, as well as the therapeutic applications of these compositions.
-
公开(公告)号：US10179816B2
公开(公告)日：2019-01-15
申请号：US15333519
申请日：2016-10-25
申请人： LABORATOIRE FRANCAIS DU FRACTIONNEMENT DES BIOTECHNOLOGIES , CENTRE REGIONAL DE LUTTE CONTRE LE CANCER , I.N.S.E.R.M. (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , UNIVERSITE MONTPELLIER 1
IPC分类号： A61K39/395 , C07K16/28 , A61K31/282 , A61K31/337 , A61K45/06 , A61K33/24 , A61K9/00 , C07K16/30 , A61K39/00
摘要： The invention relates to novel pharmaceutical compositions including, as active ingredient, an antibody binding the human anti-Müllerian hormone type II receptor (AMHR-II) and an anticancer agent, as well as the therapeutic applications of these compositions.
-
-
搜索结果
3 条记录 (耗时 0.018 秒)
